STL Volume 29 Number 2

STL Volume 29 Number 2
3 POSTS 0 COMMENTS
Purchase PDF for $2.79
image of an elderly woman checking the skin on her forearm

An Update on Current Clinical Management and Emerging Treatments in Hidradenitis Suppurativa

Explore current and emerging therapies for Hidradenitis Suppurativa (HS), a chronic, painful skin condition. This article reviews the challenges of HS treatment and introduces novel approaches including biologics like secukinumab and innovative therapies in clinical trials.
image of a young dermatologist looking into computer screen examining skin problems

Overview of Dermatological Manifestations Associated with the COVID-19 Infection

Discover the diverse dermatological manifestations in COVID-19 patients, including chilblain-like lesions, maculopapular rashes, and necrosis, reflecting the virus's complex impacts beyond respiratory symptoms. This review highlights the need for further research into these skin conditions' pathogenesis and treatment.
image collage showing pills and medical devices

Update on Drugs & Devices: March – April 2024

Update on Adalimumab-ryvk for SC injection (Simlandi®), B-Raf inhibitor gel (LUT014), Lifileucel tumorinfiltrating lymphocyte (TIL) suspension for IV use (Amtagvi™), Berdazimer topical gel, 10.3% (Zelsuvmi™), Artificial intelligencepowered skin cancer diagnostic tool (DermaSensor™), Smallpox vaccine (ACAM2000®), Oral brincidofovir (Tembexa®), Ritlecitinib tosylate capsules (Litfulo™), Ustekinumab biosimilar (Jamteki™).

POPULAR

Advertisement